Guillermo E. Umpierrez

47.3k citations

459 papers · 26.0k indexed · 18 hit papers · h-index 82

Impact in

Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Treatment and Management
Genetics top 0.05%
- Diabetes and associated disorders

Papers in

Endocrinology, Diabetes and Metabolism 382
- Diabetes Management and Research 272
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 182
- Diabetes Treatment and Management 144
- Diabetes, Cardiovascular Risks, and Lipoproteins 34
Genetics 134
- Diabetes and associated disorders 129

Co-authors: Abbas E. Kitabchi Dawn Smiley Francisco J. Pasquel Mary T. Korytkowski Joseph N. Fisher John J. Miles Irl B. Hirsch Daniel Einhorn
Journals: Diabetes Care (54 papers)Diabetes (34 papers)Endocrine Practice (33 papers)Journal of Diabetes Science and Technology (26 papers)The Journal of Clinical Endocrinology & Metabolism (24 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Guillermo E. Umpierrez

440 papers receiving 24.9k citations

Hit Papers

15 papers align trajectories log scale

Hyperglycemic Crises in Adults With Diabetes: A Consensus Report 2024 · 55 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Diabetes Care
2023 Endocrine Practice
2022 The Journal of Clinical Endocrinology & Metabolism
2021 The Lancet Diabetes & Endocrinology
2021 Current Diabetes Reports
2020 Endocrine Practice
2020 Nature Reviews Disease Primers
2019 Endocrine Practice
2018 Endocrine Practice
2017 Endocrine Practice
2016 Nature Reviews Endocrinology
2012 The Journal of Clinical Endocrinology & Metabolism
2012 Critical Care Medicine
2011 Diabetes Care
2010 Diabetes Care
2009 Diabetes Care
2009 Diabetes Care
2002 The Journal of Clinical Endocrinology & Metabolism

Peers

Countries citing papers authored by Guillermo E. Umpierrez

Since Specialization

Citations

This map shows the geographic impact of Guillermo E. Umpierrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo E. Umpierrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo E. Umpierrez more than expected).

Fields of papers citing papers by Guillermo E. Umpierrez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo E. Umpierrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo E. Umpierrez. The network helps show where Guillermo E. Umpierrez may publish in the future.

Co-authors

The 25 scholars most cited alongside Guillermo E. Umpierrez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guillermo E. Umpierrez Line = papers co-authored together Guillermo E. Umpierrez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Wearable Diabetes Technology for Hospitalized People With Diabetes and End-Stage Kidney Disease, Peripartum State, and Steroid Use Journal of Diabetes Science and Technology ·Shubham Agarwal, Andrew P. Demidowich, Diana Soliman, Guillermo E. Umpierrez, Rodolfo J. Galindo	2025	0
2	Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement British Journal of Anaesthesia ·Adriana D. Oprea, Laura J. Ostapenko, BobbieJean Sweitzer, Angela Selzer, Joan M Irizarry Alvarado, Maria D. Hurtado, Carlos E. Mendez, Kristen D. Kelley, Erin Stewart, Celia Gómez Robles, Ryan Chadha, Michael Camilleri, Ruchi Mathur, Guillermo E. Umpierrez, David L. Hepner	2025	9
3	Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice Ophthalmology Retina ·Andrew J. Barkmeier, Yihong Deng, Kavya Swarna, Jeph Herrin, Eric C. Polley, Guillermo E. Umpierrez, Rodolfo J. Galindo, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy	2025	1
4	Intermittently scanned continuous glucose monitoring adoption decreases diabetic ketoacidosis hospitalizations and healthcare costs in adults with type 1 diabetes Diabetes Research and Clinical Practice ·Pablo Rodríguez de Vera Gómez, Beatriz Rodríguez Jiménez, Eduardo Mayoral Sánchez, Francisco Jódar‐Sánchez, Reyes Ravé García, Guillermo E. Umpierrez, María Asunción Martínez-Brocca	2025	0
5	Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial Diabetes Obesity and Metabolism ·Piaopiao Li, Hamed Kianmehr, Dawei Guan, Ambar Kulshreshtha, K.M. Venkat Narayan, Mohammed K. Ali, Guillermo E. Umpierrez, Xin Hu, Vivian Fonseca, Lizheng Shi, Hui Shao	2024	2
6	Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial Journal of the American Medical Directors Association ·Thaer Idrees, Iris A. Castro-Revoredo, Hyungseok Oh, Monica Gavaller, Zohyra E. Zabala, Emmelin Moreno, Bobak Moazzami, Rodolfo J. Galindo, Priyathama Vellanki, Elena Cabb, Theodore M. Johnson, Limin Peng, Guillermo E. Umpierrez	2024	6
7	Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk Clinical Journal of the American Society of Nephrology ·Joshua J. Neumiller, Jeph Herrin, Kavya Swarna, Eric C. Polley, Rodolfo J. Galindo, Guillermo E. Umpierrez, Yihong Deng, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy	2024	2
8	Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemia Journal of Critical Care ·Greg Roberts, James S. Krinsley, Jean‐Charles Preiser, Stephen Quinn, Peter R. Rule, Michael Brownlee, Guillermo E. Umpierrez, Irl B. Hirsch	2023	4
9	Malglycemia in the critical care setting. Part I: Defining hyperglycemia in the critical care setting using the glycemic ratio Journal of Critical Care ·Greg Roberts, James S. Krinsley, Jean‐Charles Preiser, Stephen Quinn, Peter R. Rule, Michael Brownlee, Guillermo E. Umpierrez, Irl B. Hirsch	2023	5
10	Update on Measuring Ketones Journal of Diabetes Science and Technology ·Jingtong Huang, Andrea M. Yeung, Richard M. Bergenstal, Kristin Castorino, Eda Cengiz, Ketan Dhatariya, Isabella Niu, Jennifer L. Sherr, Guillermo E. Umpierrez, David C. Klonoff	2023	22
11	Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes Diabetes Care ·Candice Y. Kaminski, Rodolfo J. Galindo, José E. Navarrete, Zohyra E. Zabala, Bobak Moazzami, Amany Gerges, Rozalina G. McCoy, Maya Fayfman, Priyathama Vellanki, Thaer Idrees, Limin Peng, Guillermo E. Umpierrez	2023	10
12	Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis Diabetes Care ·David C. Klonoff, Jordan Messler, Guillermo E. Umpierrez, Limin Peng, Robby Booth, Jennifer Crowe, Valerie Garrett, Raymie McFarland, Francisco J. Pasquel	2020	60
13	Trauma exposure and stress‐related disorders in African‐American women with diabetes mellitus Endocrinology Diabetes & Metabolism ·H. Drew Dixon, Vasiliki Michopoulos, Rachel Gluck, Hadrian Mendoza, Adam Munoz, Joseph G. Wilson, Abigail Powers, Ann C. Schwartz, Guillermo E. Umpierrez, Charles F. Gillespie	2020	13
14	Hypoglycaemia and its management in primary care setting Diabetes/Metabolism Research and Reviews ·Mahmoud Ibrahim, Jason Baker, Avivit Cahn, Robert H. Eckel, Nuha Ali El Sayed, Amy Hess Fischl, Peter Gæde, Richard David Leslie, Silvia Pieralice, Dario Tuccinardi, Paolo Pozzilli, Bjørn Richelsen, Eytan Roitman, Eberhard Standl, Yoel Toledano, Jaakko Tuomilehto, Sandra Weber, Guillermo E. Umpierrez	2020	12
15	A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial Diabetes Care ·Francisco J. Pasquel, M. Cecilia Lansang, Ameer Khowaja, Maria A. Urrutia, Saumeth Cardona, Bonnie Albury, Rodolfo J. Galindo, Maya Fayfman, Georgia M. Davis, Alexandra L. Migdal, Priyathama Vellanki, Limin Peng, Guillermo E. Umpierrez	2020	23
16	Hospital Diabetes Meeting 2020 Journal of Diabetes Science and Technology ·Guillermo E. Umpierrez, Robert J Rushakoff, Jane Jeffrie Seley, Jennifer Y. Zhang, Trisha Shang, Julia Han, Elias K. Spanakis, Sara Alexanian, Andjela Drincic, Kristen Kulasa, Carlos E. Mendez, Damon Tanton, Amisha Wallia, Mihail Zilbermint, David C. Klonoff	2020	12
17	Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital Diabetes Care ·Guillermo E. Umpierrez, David C. Klonoff	2018	154
18	Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important? Diabetes Research and Clinical Practice ·Riccardo C. Bonadonna, Éric Renard, Alice Cheng, Andreas Fritsche, Anna M. G. Cali, Lydie Melas‐Melt, Guillermo E. Umpierrez	2018	11
19	Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes Diabetes Care ·Virginia Bellido, Lorena Suárez, María Galiana Rodríguez Caballero, Cecilia Sánchez-Ragnarsson, Marta Diéguez, María Riestra Fernández, Florentino Casal, Elías Delgado, Edelmiro Menéndez Torre, Guillermo E. Umpierrez	2015	77
20	Hyperglycemic Crises in Urban Blacks Archives of Internal Medicine ·Guillermo E. Umpierrez	1997	207

About Guillermo E. Umpierrez

Guillermo E. Umpierrez is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Cardiology and Cardiovascular Medicine, Pharmacy and Physiology, having authored 459 papers that have together received 26.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (272 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (182 papers), Diabetes Treatment and Management (144 papers), Diabetes and associated disorders (129 papers), Metabolism, Diabetes, and Cancer (53 papers), Pancreatic function and diabetes (44 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers) and Diet and metabolism studies (32 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (20.0k citations), Genetics (7.6k citations), Surgery (5.4k citations), Physiology (3.0k citations) and Cardiology and Cardiovascular Medicine (2.5k citations). Guillermo E. Umpierrez has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Abbas E. Kitabchi, Dawn Smiley, Francisco J. Pasquel, Mary T. Korytkowski, Joseph N. Fisher, John J. Miles, Irl B. Hirsch, Daniel Einhorn, Scott Isaacs and Limin Peng. Their work appears in journals such as Diabetes Care, Diabetes, Endocrine Practice, Journal of Diabetes Science and Technology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact